Skip to main content
COCO logo

COCO · Vita Coco Company, Inc.

Track COCO — free
$63.12 -1.58 (-2.44%) At close · Nov 13
Market Cap
$3.60B
Shares
57.06M
Volume · Nov 13 659.72K Avg daily vol (3M) 1.26M

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$63.12 Open$64.77 Day$62.58–65.29 52W close$43.13–84.02 Avg vol 30d1.3M Short int7.1M · 12.4% of shares · 4.4d Short vol85% Last earningsOct 22, 2026 DataOct 2021–Nov 2026 Filing10-Q · Oct 22

Up next

Feb 17, 2027 Est · unconfirmed · in 13 wks

Latest documents

2026
Oct 22
Earnings call
Q3 2026 earnings call

Vita Cocoa Company reported third-quarter net sales up 34%, raised full-year net sales guidance to between $810 and $820 million and adjusted EBITDA guidance to $170 to $175 million dollars, while supply constraints reduced service levels and pricing adjustments are planned for early 2027.

Read from the first part of this long document
Oct 22
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Vita Coco Company completed the Copra Inc. acquisition on July 22, 2026, and consolidated net sales increased 32.7% for the nine months ended September 30, 2026. Tariff refunds totaling approximately $15.6 million provided a one-time benefit to results.

Revenue $243.83M ▲ 33.7% Net income $35.02M ▲ 45.9% Diluted EPS $0.58 ▲ 45.0%
Read from the MD&A section
Oct 22
Current report 8-K
Financial results

Vita Coco reported third-quarter net sales of $244 million, up 34%, and Adjusted EBITDA of $53 million, and raised Fiscal Year 2026 guidance to between $810 million and $820 million in net sales and $170 million and $175 million in Adjusted EBITDA.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$767.53M
Trailing 12 months
Net income (TTM)
$120.47M
Trailing 12 months
Revenue growth YoY
+33.7%
Year over year
Operating margin
19.9%
Trailing 12 months
P / E (TTM)
31.6
Trailing earnings · reciprocal yield 3.2%
FCF yield
4.0%
TTM · current market cap
Return on invested capital
42.7%
Trailing 12 months
Net cash
$152.00M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.6%
Year over year · more shares
Price change (1Y)
+46.3%
Trailing year
Short interest
12.4%
Latest settlement · 4.4 days to cover
View all 125 metrics

AI Brief

Q3 FY26 earnings call · Oct 22, 2026
Q3 FY26

TL;DR. Vita Coco raised fiscal 2026 net sales and adjusted EBITDA guidance after third-quarter net sales increased 34% and organic growth reached 18%. Fourth-quarter gross margin is expected to fall to approximately 33%, while supply constraints have reduced service levels and left shipments below retail demand.

Bullish
  • + Raised full-year net sales guidance to $810 million-$820 million from $790 million-$805 million.
  • + Raised full-year adjusted EBITDA guidance to $170 million-$175 million from $154 million-$161 million.
  • + The category maintained strong growth through the fall, with Vita Coco growth supported by household penetration and consumption per household.
  • + Copra contributed to third-quarter growth and is expected to support the company's super-premium segment.
  • + The balance sheet remained strong with $152 million of cash and no debt.
Bearish
  • − Fourth-quarter gross margin is expected to decline to approximately 33%.
  • − Ocean freight, transportation and packaging cost increases pressured margins and are expected to weigh on fourth-quarter gross margin.
  • − Supply constraints reduced service levels and caused shipments to lag retail scan growth.
  • − Private-label growth and Copra's mix diluted gross margin.
  • − Capacity is expected to remain tight in the first half of 2027, limiting sales upside.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Neutral Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +1%
above
Price vs 50-day avg +9%
above
RSI (14) 56
neutral
MACD trend Positive
52-week position 49%
mid-range
Volume (OBV) Bearish div.
distributing
Momentum
relative strength
Neutral
1-month return +8%
trailing
6-month return −17%
trailing
YTD return +19%
this year
Relative strength −18%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $58 › 200d $62 — 200d above 50d
Institutional flow Accumulating
312 of 348 funds reported for Sep 30 · net +6.9M sh shares · +53 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
12.45% of shares out · ▲ +2.7% MoM · 4.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
348 holders — near 3-yr high, broad support
Squeeze score 76
high risk · 0–100
Fundamentals
Excellent
Revenue growth +18%
Y/Y
Gross margin 37%
contracting
EPS growth +27%
Y/Y
Free cash flow $39.0M
Valuation P/E 31.6
below peers
Buyback $10.9M
remaining
Balance sheet $196.9M
net cash
Quant / Vol
risk profile
Very High
Volatility 57%
annualized · 1-yr
Max drawdown −40%
past year
ATR 4.9%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 3
Latest guidance · from the 8-K filed Oct 22, 2026
full year 2026
Net sales Raised $810M – $820M
Jul 23, 2026 $790M – $805M changed to Oct 22, 2026 $810M – $820M
prior FY $609.78M midpoint +33.7% Y/Y
Gross margin Maintained 40%
Jul 23, 2026 40% changed to Oct 22, 2026 40%
SG&A leverage 1.5%
Adjusted EBITDA Non-GAAP Raised $170M – $175M
Jul 23, 2026 $154M – $161M changed to Oct 22, 2026 $170M – $175M
Fourth quarter
Gross margin 33%
Previous outlook earlier release · from the Earnings Call filed Jul 23, 2026

Still-open targets the latest release did not restate under the same label.

U.S. private label net sales growth · full year 2026 90% – 100%
Full-year private label net sales growth in the U.S. · full-year 90% – 100%
Capital expenditure to double extraction output and improve effi · 2026 $11M
U.S. private label full year growth · full year 90% – 100%
Guided vs delivered · last 3 settled
Net sales full year 2025
guided $580M – $595M
$609.78M Beat +3.8%
Net sales 2024
guided $500M – $510M
$516.01M Beat +2.2%
Net sales full year 2022
guided $422M – $427M
$427.79M Beat +0.8%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 3
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+1% Bullish
Price vs 50-day avg
+9% Bullish
RSI (14)
56 Neutral
MACD trend
Positive Bullish
52-week position
49% Neutral
Volume (OBV)
Bearish div. Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $58 › 200d $62 — 200d above 50d
Institutional flow Accumulating
312 of 348 funds reported for Sep 30 · net +6.9M sh shares · +53 new
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
12.45% of shares out · ▲ +2.7% MoM · 4.4 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
348 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $43 Now $63 · 49% Range high $84
vs 200-day avg +1% vs 50-day avg +9%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Organic net sales growth non-GAAP 26.7% Nine Months Ended September 30, 2026 —
EBITDA non-GAAP 62.36M Three Months Ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net income 49.45M
+489K Depreciation and amortization
-2.48M Interest income, net
+14.91M Income tax expense
= EBITDA 62.36M

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Beverages - Non-Alcoholic — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
COCO
Vita Coco Company, Inc.
this stock
$3.60B +19.1% +18.2% 31.6 12.4%
KO
Coca Cola Co
$426.96B +42.0% +1.9% 29.2 1.1%
PEP
Pepsico Inc
$198.20B +1.3% +2.3% 18.3 2.0%
MNST
Monster Beverage Corp
$90.95B — +10.7% 41.9 2.4%
NNFSF
Nongfu Spring Co. Ltd.
$59.16B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
368
% held
100.2%
Reported
312 of 348
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
368
View
Short & Settlement
Short Interest Rising
Shares short
7.1M
Days to cover
4.4d
Change
+186.0K sh
View
Short Volume
Short vol %
85%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
1.6K
Value
$91.1K
As of
Oct 6, 2026
View
Off-Exchange
Off-exchange %
41.1%
Week of
Oct 5, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Buy
Member
Gilbert Cisneros
Amount
$1.0K–$15.0K
Traded
Sep 17, 2026
View
Financials
Financials
Net income (FY)
$71.3M
EPS diluted
$1.19
View
Buybacks
Authorized
$105.0M
Remaining
$10.9M
Spent Remaining
View
Filings
SEC Filings
Latest
10-Q
Filed
Oct 22, 2026
This year
20

Vita Coco Company completed the Copra Inc. acquisition on July 22, 2026, and consolidated net sales increased 32.7% for the nine months ended September 30, 2026. Tariff refunds totaling approximately $15.6 million provided a one-time benefit to results.

View
Proposed Sales
Value
$325.0K
Shares
5.0K
Filed
Nov 4, 2026
View
Exempt Offerings
Offering
$135.0M
Filed
Aug 6, 2026
View
Earnings & Events
Webcasts
Last webcast
Oct 22, 2026
View
Investor Relations
Latest news
Vita Coco® Introduces Vita Coco K…
Published
Oct 27, 2026
View

Performance

5D 20D 120D MTD YTD
COCO +1.1% +7.6% -17.5% +7.9% +19.1%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY -1.5% +8.7% -18.0% +8.1% +8.5%

Capital returns

Buyback program · as of Oct 21, 2026
Authorized
$105.00M
Spent (derived)
$94.10M
Remaining
$10.90M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1482981 CUSIP 92846Q107 13F (30d) 280 filings 256 filers Visit website Investor relations